Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Lonca
Lonca
FDA sets May date for verdict on ADC’s lymphoma drug Lonca
Pharmaforum
Mon, 11/23/20 - 10:20 am
ADC Therapeutics
Lonca
diffuse large B-cell lymphoma
FDA
priority review
ADC gets priority review for anti-CD19 blood cancer drug
Fierce Biotech
Fri, 11/20/20 - 11:12 am
FDA
ADC Therapeutics
antibody-drug conjugate
Lonca
relapsed or refractory diffuse large B-cell lymphoma